Physician profile
Edwin E Morales
NPI 1821232836
$4,188.77
in general payments reported to CMS, 2019-2025
25 companies · $2,755 in 2025
The $2,755 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.14 · 2021: $91.14 · 2022: $359 · 2023: $347 · 2024: $618 · 2025: $2,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $1,225 · Travel and Lodging: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $1,225.03 |
| Travel and Lodging | $994.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,511.93 | 2025 | |
| Astellas Pharma US INC | $381.10 | 2022-2024 | Xtandi, Myrbetriq, Veozah |
| Urogen Pharma, INC. | $244.43 | 2023-2025 | Jelmyto |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $135.70 | 2022-2025 | Lithovue |
| Hollister Incorporated | $135.33 | 2021-2022 | |
| Abbvie INC. | $84.78 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $77.89 | 2023-2025 | Orgovyx |
| Endo USA, INC. | $59.93 | 2024 | Xiaflex |
| Coloplast Corp | $59.50 | 2024 | |
| Myovant Sciences INC. | $43.78 | 2021-2022 | |
| Accord Healthcare, INC. | $38.71 | 2024 | |
| 180 Medical, INC. | $33.90 | 2024 | |
| Steris Corporation | $32.42 | 2024 | |
| Myriad Genetic Laboratories, INC. | $29.49 | 2025 | Prolaris |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $23.81 | 2023 | Stravix Pl |
| Civco Medical Instruments | $21.37 | 2024 | |
| Endo Pharmaceuticals INC. | $21.02 | 2024 | Aveed, Xiaflex, Edex |
| Melinta Therapeutics, LLC | $19.14 | 2020 | |
| Axonics, INC. | $19.01 | 2024 | Bulkamid |
| Progenics Pharmaceuticals, INC. | $18.95 | 2024 | |
| Procept Biorobotics Corporation | $18.57 | 2024 | Aquabeam System |
| Allergan, INC. | $18.24 | 2021 | |
| Blue Earth Diagnostics | $15.37 | 2024 | |
| Mission Pharmacal Company | $6.73 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.